Physician profile
David Deboer
NPI 1346242559
$14,341.01
in general payments reported to CMS, 2019-2025
22 companies · $2,219 in 2025
The $2,219 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,821 · 2020: $1,448 · 2021: $1,668 · 2022: $391 · 2023: $1,925 · 2024: $2,869 · 2025: $2,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,940 · Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,939.89 |
| Food and Beverage | $3,073.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,685.30 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Konect Resilia |
| Abbott Laboratories | $2,267.98 | 2019-2025 | Epic |
| Abiomed | $1,771.28 | 2019-2024 | Impella |
| Davol INC. | $1,753.38 | 2019-2024 | Progel Applicator Spray Tips |
| Angiodynamics, INC. | $1,481.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $1,261.08 | 2019-2024 | |
| Baxter Healthcare | $1,151.53 | 2020-2023 | |
| Medtronic, INC. | $222.21 | 2021-2025 | Vitalflow Console |
| Atricure, INC. | $145.29 | 2019-2024 | |
| Depuy Synthes Sales INC. | $116.87 | 2021 | |
| La Jolla Pharmaceutical Company | $101.34 | 2025 | Giapreza |
| Ethicon US, LLC | $68.57 | 2020-2024 | Vistaseal |
| Astrazeneca Pharmaceuticals LP | $64.31 | 2022 | |
| Pfizer INC. | $57.97 | 2024-2025 | |
| Cook Medical LLC | $45.12 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $36.78 | 2020 | |
| Amgen INC. | $24.52 | 2023 | Repatha |
| Janssen Pharmaceuticals, INC | $24.06 | 2024 | Xarelto |
| Csl Behring | $19.41 | 2020 | |
| Haemonetics Corporation | $16.59 | 2025 | Teg6s Hemostasis System |
| Biomerieux INC | $13.25 | 2019 | |
| Lemaitre Vascular, INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Deboer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.